Telangana pharma plant explosion: 12 killed, 34 injured, says state Minister
Sangareddy (Telangana), Jun 30 (PTI): At least 12 people died and 34 persons were injured in a pharma plant explosion in this district on Monday, Telangana Minister Damodara Raja Narasimha said.
"As many as 12 people died and 34 people are under treatment. We are hopeful that there would be no more (deaths)," the health minister told reporters.
Labour Minister G Vivek Venkatswamy said: "Eight people died in the morning. Now, four bodies were found."
Both the ministers visited the site.
The explosion took place at a reactor in the plant of Sigachi pharma company in the Pashamylaram industrial estate due to the suspected chemical reaction where fire also broke out.
Earlier, Inspector General of Police (Multizone) V Satyanarayana, quoting factory sources, said there were 150 people in the factory at the time of the blast. Ninety persons were in the same area where the explosion occurred.
He said the explosion occurred between 9.28 am and 9.35 am. The management immediately reached out to the local police who in turn alerted the fire department.
About ten fire fighting engines were pressed into service, he further said, adding the personnel of NDRF and SDRF were also engaged in the rescue operation.
The fire was brought under control, he added.
Asked how many workers were working at the time of the tragedy, he said effort was on to ascertain the exact figure as the person who maintains record of the workers' details is believed to have died.
Prime Minister Narendra Modi expressed grief over the fire tragedy and conveyed condolences to those who lost their loved ones in the incident. He wished an early recovery to the injured.
In a post on 'X', he announced an ex-gratia of Rs 2 lakh from the Prime Minister's National Relief Fund for the next of kin of the deceased and Rs 50,000 for the injured.
Chief Minister A Revanth Reddy expressed anguish over the incident and directed officials to take all steps to save the trapped workers and provide them advanced medical care, an official release said.
Sigachi Industries Limited is a pharmaceutical company dedicated to pioneering advancements in Active Pharmaceutical Ingredients (APIs), Intermediates, Excipients, vitamin-mineral blends, and Operations and Management (O&M) services, according to the company's website.
There was no immediate reaction from the company.
Let the Truth be known. If you read VB and like VB, please be a VB Supporter and Help us deliver the Truth to one and all.
ED arrests Sandeepa Virk, 'cosmetologist' for alleged money laundering
New Delhi, Aug 13 (PTI): The Enforcement Directorate said on Wednesday it has arrested a woman, who claims to be an actor and a cosmetologist, under the anti-money laundering law in a case of alleged fraud and misrepresentation.
The agency said the purported links of the woman, Sandeepa Virk, with a Reliance Group executive, Angarai Natarajan Sethuraman (President, Corporate Affairs), are also under its scanner. Sethuraman, in a statement, denied any connection with Virk or any transactions related to her.
Virk was taken into custody under the Prevention of Money Laundering Act (PMLA) on Tuesday after searches were conducted against her and her associates in Delhi and Mumbai over the last two days.
A special court sent her to the ED's custody till August 14, the agency said. The woman claims to be the owner of a skin care products selling website named hyboocare.com, which the ED claimed was a "front" for money laundering.
She and her associates are being probed for allegedly exerting undue influence through "misrepresentation" and "defrauding" individuals by soliciting money under false pretences.
According to an Instagram ID of Virk, she is an actor and entrepreneur and the founder of the said website.
The federal agency said in a statement that the woman was also "in touch with" Sethuraman, former director of erstwhile Reliance Capital Limited.
She was communicating with him regarding "illegal liaisoning", the ED claimed, adding that the searches at Sethuraman's residence "confirmed" these allegations.
"Besides, diversion of funds for personal benefit has also been unearthed during the course of the search action," it said.
The ED alleged that public money worth about Rs 18 crore belonging to Reliance Commercial Finance Limited (RCFL) was disbursed to Sethuraman in 2018 by "flouting" prudent lending norms.
The funds were lent under terms that allowed a deferment of the principal amount as well as the interest, with multiple waivers granted and no due diligence conducted, it said.
The ED claimed that besides this, a home loan of Rs 22 crore was provided by Reliance Capital Limited by "violating" the prudential norms. "A large part of these loans are seen to have been eventually siphoned off and remained unpaid," it alleged.
Sethuraman, in a statement, dismissed the allegations as "baseless". He denied any connection with Virk or any transactions related to her.
Detailing about Virk's web portal, the agency said it purportedly sold FDA-approved beauty products. However, the ED said the products listed on the website have been found to be non-existent and the portal lacks a user registration option and is plagued by persistent payment gateway issues.
A scrutiny of the website uncovered minimal social-media engagement, an inactive WhatsApp contact number and an absence of transparent organisational details, all of which reinforce the finding of "non-genuine" commercial activity, the ED claimed.
"These factors, including limited product range, inflated pricing, false claims of FDA approval and technical inconsistencies, indicate that the website serves as a front for laundering funds," it said.
Another social media-hosted bio data of the woman said she is a certified cosmetologist.
The ED said several "incriminating" documents were seized during the searches and the statement of a man named Farrukh Ali, stated to be an associate of Virk, was recorded.
The money-laundering case stems from an FIR lodged by the Punjab Police.
Sethuraman said that the home loan he received from Reliance Capital was granted following due process and was secured by the property offered as collateral.
